| Fair Value Measurements |
Note
4. Fair Value Measurements
The
Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows:
Schedule
of Fair Value Assets and Liabilities Measured on Recurring Basis
| |
|
Level
1 |
|
|
Level
2 |
|
|
Level
3 |
|
|
Total |
|
| |
|
Fair
Value Measured as of December 31, 2024 |
|
| |
|
Level
1 |
|
|
Level
2 |
|
|
Level
3 |
|
|
Total |
|
| |
|
(In
thousands) |
|
| Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Money
market funds (i) |
|
|
215 |
|
|
|
— |
|
|
|
— |
|
|
|
215 |
|
| Corporate
bonds (ii) |
|
|
— |
|
|
|
6,621 |
|
|
|
— |
|
|
|
6,621 |
|
| Total
financial assets |
|
$ |
215 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
215 |
|
| Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common
stock warrant liabilities (2022 Private Warrant) (iii) |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
1 |
|
|
$ |
1 |
|
| Common
stock warrant liabilities (RDO Warrants) (iii) |
|
|
— |
|
|
|
— |
|
|
|
90 |
|
|
|
90 |
|
| Common
stock warrant liabilities (Placement Agent Warrants) (iii) |
|
|
— |
|
|
|
— |
|
|
|
16 |
|
|
|
16 |
|
| Common
stock warrant liabilities (2024 Private Warrants) (iii) |
|
|
— |
|
|
|
— |
|
|
|
378 |
|
|
|
378 |
|
| Common
stock warrant liabilities (BEPO Warrants) (iii) |
|
|
— |
|
|
|
— |
|
|
|
18 |
|
|
|
18 |
|
| Common
stock warrant liabilities (BEPO Agent Warrants) (iii) |
|
|
— |
|
|
|
— |
|
|
|
2 |
|
|
|
2 |
|
| Common
stock warrant liabilities (July 2024 Private Warrants) (iii) |
|
|
— |
|
|
|
— |
|
|
|
865 |
|
|
|
865 |
|
| Common
stock warrant liabilities (August Inducement Warrants) (iii) |
|
|
— |
|
|
|
— |
|
|
|
796 |
|
|
|
796 |
|
| Contingent
earnout liabilities |
|
|
— |
|
|
|
— |
|
|
|
11 |
|
|
|
11 |
|
| Total
financial liabilities |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
2,177 |
|
|
$ |
2,177 |
|
| |
|
Level
1 |
|
|
Level
2 |
|
|
Level
3 |
|
|
Total |
|
| |
|
Fair
Value Measured as of December 31, 2023 |
|
| |
|
Level
1 |
|
|
Level
2 |
|
|
Level
3 |
|
|
Total |
|
| |
|
(In
thousands) |
|
| Assets |
|
|
|
|
|
|
|
|
|
|
|
|
| Money
market funds (i) |
|
$ |
3,422 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
3,422 |
|
| Corporate
bonds (ii) |
|
|
— |
|
|
|
6,621 |
|
|
|
— |
|
|
|
6,621 |
|
| Total
financial assets |
|
$ |
3,422 |
|
|
$ |
6,621 |
|
|
$ |
— |
|
|
$ |
10,043 |
|
| Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common
stock warrant liabilities (Public) (iii) |
|
$ |
258 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
258 |
|
| Common
stock warrant liabilities (Private Placement) (iii) |
|
|
— |
|
|
|
— |
|
|
|
127 |
|
|
|
127 |
|
| Common
stock warrant liabilities (2022 Private Warrant) (iii) |
|
|
— |
|
|
|
— |
|
|
|
23 |
|
|
|
23 |
|
| Common
stock warrant liabilities (RDO Warrants) (iii) |
|
|
— |
|
|
|
— |
|
|
|
10,891 |
|
|
|
10,891 |
|
| Common
stock warrant liabilities (Placement Agent Warrants) (iii) |
|
|
— |
|
|
|
— |
|
|
|
536 |
|
|
|
536 |
|
| Warrant liabilities |
|
|
— |
|
|
|
— |
|
|
|
536 |
|
|
|
536 |
|
| Contingent
earnout liabilities |
|
|
— |
|
|
|
— |
|
|
|
1,456 |
|
|
|
1,456 |
|
| Total
financial liabilities |
|
$ |
258 |
|
|
$ |
— |
|
|
$ |
13,033 |
|
|
$ |
13,291 |
|
| (i) |
|
Included in cash and cash equivalents
on the consolidated balance sheets. |
| (ii) |
|
Included in short-term
investments on the consolidated balance sheets. |
| (iii) |
|
Included in warrant
liabilities on the consolidated balance sheets. |
For
more information regarding the Public Warrants, the Private Placement Warrants, the 2022 Private Warrants, the RDO Warrants, the Placement
Agent Warrants, the 2024 Private Warrants, the BEPO warrants, the BEPO Agent Warrants, the July 2024 Private Warrants, the August Inducement
Warrants, and the Contingent earnout liabilities, see Note 10, Equity Instruments.
The
aggregate fair value of the Company’s money market funds approximated amortized cost and, as such, there were no unrealized gains
or losses on money market funds as of December 31, 2024 and 2023. Realized gains and losses, net of tax, were not material for any of
the periods presented.
Velo3D,
Inc.
Notes
to Consolidated Financial Statements
The
following table presents a summary of the changes in the fair value of the Company’s Level 3 financial instruments:
Summary
of Changes in Fair Value of Level 3 Financial Instruments
| |
|
Private
placement warrant liabilities |
|
|
2022
Private Warrant |
|
|
Contingent
earnout liabilities |
|
|
Debt
derivatives |
|
|
RDO
Warrants |
|
|
Placement
Agent Warrants |
|
|
2024
Private Warrants |
|
|
BEPO
Warrants |
|
|
BEPO
Agent Warrants |
|
|
July
2024 Private Warrants |
|
|
August
Inducement Warrants |
|
| |
|
(In
Thousands) |
|
| Fair
value as of January 1, 2024 |
|
$ |
127 |
|
|
$ |
23 |
|
|
$ |
1,456 |
|
|
$ |
— |
|
|
$ |
10,891 |
|
|
$ |
536 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
| Issuance of instruments |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
6,321 |
|
|
|
9,020 |
|
|
|
446 |
|
|
|
4,200 |
|
|
|
2,437 |
|
| Change
in fair value |
|
|
(127 |
) |
|
|
(22 |
) |
|
|
(1,445 |
) |
|
|
— |
|
|
|
(10,801 |
) |
|
|
(520 |
) |
|
|
(6,319 |
) |
|
|
(8,642 |
) |
|
|
(428 |
) |
|
|
(3,335 |
) |
|
|
(1,641 |
) |
| Extinguishment
of debt derivatives in connection with debt extinguishment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair
value as of December 31, 2024 |
|
$ |
— |
|
|
$ |
1 |
|
|
$ |
11 |
|
|
$ |
— |
|
|
$ |
90 |
|
|
$ |
16 |
|
|
$ |
2 |
|
|
$ |
378 |
|
|
$ |
18 |
|
|
$ |
865 |
|
|
$ |
796 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value as
of January 1, 2023 |
|
$ |
888 |
|
|
$ |
109 |
|
|
$ |
17,414 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
| Fair value,
Beginning Balance |
|
$ |
888 |
|
|
$ |
109 |
|
|
$ |
17,414 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
| Issuance of instruments |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
13,890 |
|
|
|
10,891 |
|
|
|
536 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Change
in fair value |
|
|
(761 |
) |
|
|
(86 |
) |
|
|
(15,958 |
) |
|
|
(8,485 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Extinguishment
of debt derivatives in connection with debt extinguishment |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(5,405 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Fair
value as of December 31, 2023 |
|
$ |
127 |
|
|
$ |
23 |
|
|
$ |
1,456 |
|
|
$ |
— |
|
|
$ |
10,891 |
|
|
$ |
536 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
| Fair
value, Ending Balance |
|
$ |
127 |
|
|
$ |
23 |
|
|
$ |
1,456 |
|
|
$ |
— |
|
|
$ |
10,891 |
|
|
$ |
536 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
The
fair value of the Private placement warrant liability, the 2022 Private Warrant liability, the Contingent earnout liability, the Debt
derivative liability, the RDO Warrant liability, the Placement Agent Warrant liability, the 2024 Private Warrant liability, the BEPO
warrant liability, the BEPO Agent Warrant liability, the July 2024 Private Warrant liability, and the August Inducement Warrant liability
are based on significant unobservable inputs, which represent Level 3 measurements within the fair value hierarchy.
In
determining the fair value of the Private placement warrant liability, Contingent earnout liability, Debt derivative liability and the
2024 Private Warrant liability, the Company used the Monte Carlo simulation model using a distribution of potential outcomes on a weekly
basis over the applicable periods that assumes optimal exercise of the Company’s redemption option at the earliest possible date
(see Note 10, Equity Instruments).
In
determining the fair value of the 2022 Private Warrant liability, RDO Warrant liability, Placement Agent Warrant liability, BEPO Warrant
liability, BEPO Agent Warrant liability, July 2024 Private Warrant liability and August Inducement Warrant liability the Company used
the Black-Scholes option pricing model to estimate the fair value using unobservable inputs including the expected term, expected volatility,
risk-free interest rate and dividend yield (see Note 10, Equity Instruments).
|